类风湿关节炎相关间质性肺病基于纵向用力肺活量轨迹的异质性及其与疾病结局的关联
该队列研究在1999至2021年退伍军人健康管理局的类风湿关节炎相关间质性肺病(RA-ILD)患者中,基于纵向用力肺活量(FVC)识别轨迹分组,并分析其与生存和呼吸相关住院的关联。主要队列(n=1,092)得出3个轨迹组,总体队列(n=5,172)得出8个轨迹组;进展组占主要队列82.5%、总体队列54%。相对于稳定组,慢速和快速进展者的死亡及呼吸相关住院风险升高。
要点
- 主要队列82.5%、总体队列54%的RA-ILD患者属于FVC进展组。
- 主要队列中慢速进展者死亡aHR 1.55、呼吸住院aHR 1.38,快速进展者分别为2.07和1.77。
- 总体队列中进展轨迹者死亡aHR范围1.18-2.69,呼吸住院aHR范围1.29-2.78。
核心结论
- 基于纵向FVC值的独特疾病轨迹与RA-ILD患者的死亡和呼吸相关住院风险独立相关。
- 识别这些独特的RA-ILD轨迹可为管理和监测提供信息。
研究设计与样本
- 1999至2021年在退伍军人健康管理局开展的RA-ILD队列研究,采用经验证的算法识别患者。
- 使用基于组的轨迹模型,在具有基线和随访FVC值的主要队列(n=1,092)及至少一次FVC值的总体队列(n=5,172)中识别轨迹组。
- 采用多变量Cox回归模型检验轨迹分组与生存及呼吸相关住院的关联,并校正初始FVC。
主要发现
- 主要队列得出3个FVC轨迹组,总体队列得出8个轨迹组。
- 主要队列中82.5%、总体队列中54%的患者属于进展组,FVC占预计值百分比年变化范围主要队列为-2.16至-10.78,总体队列为-0.73至-1.56。
- 相对于稳定组,主要队列中慢速进展者死亡aHR 1.55、呼吸相关住院aHR 1.38,快速进展者死亡aHR 2.07、呼吸相关住院aHR 1.77。
- 总体队列中,FVC进展轨迹患者的死亡风险升高(aHR范围1.18-2.69),呼吸相关住院风险升高(aHR范围1.29-2.78)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to identify unique disease trajectories within rheumatoid arthritis-associated interstitial lung disease (RA-ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. METHODS: We performed a cohort study of RA-ILD within the Veterans Health Administration from 1999 to 2021. Patients with RA-ILD were identified with validated algorithms. Group-based trajectory modeling was used to identify unique groups based on longitudinal FVC values in a primary cohort with baseline and follow-up FVC values and an overall cohort with at least one FVC value. Associations of group assignment with survival and respiratory hospitalization were tested in multivariable Cox regression models adjusting for initial FVC. RESULTS: We derived three FVC trajectory groups in the primary cohort (n = 1,092) and eight in the overall cohort (n = 5,172). A total of 82.5% (primary cohort) and 54% (overall cohort) of patients with RA-ILD belonged to progressive groups with FVC percent predicted change ranging from -2.16 to -10.78 (primary) and -0.73 to -1.56 (overall) per year. Relative to the stable group, slow (adjusted hazard ratio [aHR] 1.55 and 1.38) and rapid (aHR 2.07 and 1.77) progressors in the primary cohort had an increased risk of death and respiratory hospitalization, respectively. In the overall cohort, patients with a progressive FVC trajectory also experienced an increased risk of death (aHR range 1.18-2.69) and respiratory hospitalization (aHR range 1.29-2.78). CONCLUSION: Unique disease trajectories based on longitudinal FVC values are independently associated with the risk of death and respiratory-related hospitalization in RA-ILD. Recognition of these unique RA-ILD trajectories could inform management and monitoring.
引用
- England BR, Yang Y, Roul P, et al. Heterogeneity of Rheumatoid Arthritis-Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes. Arthritis Care Res (Hoboken). 2025. PMID: 40771150. doi:10.1002/acr.25620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。